-
1
المؤلفون: Marco Pavesi, Moisés Mira Flores, Aurea Duran, Josep Gumà, Alessandra Pranzo, Alexis Serikoff, Bernard Rappe, Angus Robinson, Serena Hilman, Benoit Baron, Louis-Marie Dourthe, D. Mott, Steven Joniau, M. Herdman, Stéphane Mallick, Roberto Bordonaro, Maria De Santis, Ugo De Giorgi, Heather Payne
المصدر: International Journal of Cancer. 150:837-846
مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, THERAPY, law.invention, Prostate cancer, chemistry.chemical_compound, Randomized controlled trial, QUALITY-OF-LIFE, law, Internal medicine, Nitriles, Phenylthiohydantoin, Clinical endpoint, Humans, Medicine, Enzalutamide, Prospective Studies, Neoplasm Metastasis, Aged, DOCETAXEL, Aged, 80 and over, Science & Technology, enzalutamide, business.industry, PAIN, MEN, ABIRATERONE, Middle Aged, Prostate-Specific Antigen, medicine.disease, Discontinuation, Europe, Clinical trial, Prostatic Neoplasms, Castration-Resistant, metastatic castration-resistant prostate cancer, chemistry, Docetaxel, Benzamides, Cohort, Quality of Life, business, Life Sciences & Biomedicine, medicine.drug
وصف الملف: Print-Electronic
-
2
المؤلفون: Georgina Arrambide, Ingrid van der Mei, Raed Alroughani, Lars Forsberg, Rodden M. Middleton, Guilherme Sciascia do Olival, Nikola Lazovski, Rumen Ivanov, Alexander Stahmann, Tomas Kalincik, Helmut Butzkueven, Richard S. Nicholas, J. Hillert, Alice Estavo Dias, Edward De Brouwer, Amber Salter, Serkan Ozakbas, Nupur Nag, Doralina Guimarães Brum, Alexander Fidao, Anna Zabalza, Yves Moreau, Ricardo Alonso, Anneke Van Der Walt, Nick Rijke, Lotte Geys, Anibal Chertcoff, Arnfin Bergmann, Robert N. McBurney, Clare Walton, Anna Glaser, Tina Parciak, Gilles Edan, Clément Gautrais, Ashkan Pirmani, Maria Fernanda Mendes, Juan Ignacio Rojas, Melinda Magyari, Liesbet M. Peeters, Robert J. Fox, Hollie Schmidt, Amin Ardeshirdavanai, Steve Simpson-Yap, Stefan Braune, Giancarlo Comi, Johana Bauer, Tim Spelman
المساهمون: Zabalza, Ana/0000-0003-3860-5251, Simpson, Jr., Steve/0000-0001-6521-3056, Kalincik, Tomas/0000-0003-3778-1376, Simpson-Yap, Steve, DE BROUWER, Edward, Kalincik, Tomas, Rijke, Nick, Hillert, Jan A., Walton, Clare, Edan, Gilles, Moreau, Yves, Spelman, Tim, GEYS, Lotte, PARCIAK, Tina, Gautrais, Clement, Lazovski, Nikola, PIRMANI, Ashkan, Ardeshirdavanai, Amin, Forsberg, Lars, Glaser, Anna, McBurney, Robert, Schmidt, Hollie, Bergmann, Arnfin B., Braune, Stefan, Stahmann, Alexander, Middleton, Rodden, Salter, Amber, Fox, Robert J., van der Walt, Anneke, Butzkueven, Helmut, Alroughani, Raed, Ozakbas, Serkan, Rojas, Juan, I, van der Mei, Ingrid, Nag, Nupur, Ivanov, Rumen, do Olival, Guilherme Sciascia, Dias, Alice Estavo, Magyari, Melinda, Brum, Doralina, Mendes, Maria Fernanda, Alonso, Ricardo N., Nicholas, Richard S., Bauer, Johana, Chertcoff, Anibal Sebastian, Zabalza, Anna, Arrambide, Georgina, Fidao, Alexander, Comi, Giancarlo, PEETERS, Liesbet, Institut Català de la Salut, [Simpson-Yap S] Department of Medicine, and Neuroepidemiology Unit, Melbourne School of Population & Global Health, University of Melbourne, Parkville, Australia. Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia [De Brouwer E] University of Tasmania, Hobart, Australia. ESAT-STADIUS, KU Leuven, Belgium. [Kalincik T] Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, Australia. [Rijke N, Walton C] MS International Federation, London, UK. [Hillert JA] Department of Clinical Neuroscience, Swedish MS Registry, Stockholm, Sweden. [Zabalza A, Arrambide G] Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus, and Neuroepidemiology Unit, Melbourne School of Population and Global Health, University of Tasmania, KU Leuven, Royal Melbourne Hospital, MS International Federation, Swedish MS Registry, CHU Pontchaillou, Karolinska Institutet, Hasselt University, University Medical Center, QMENTA, Molecular Unit, Accelerated Cure Project for MS, NeuroTransData, MS Forschungs- und Projektentwicklungs-gGmbH, Swansea University, COViMS, Washington University in St. Louis, Cleveland Clinic, Monash University, Kuwait City, Dokuz Eylul University, Hospital Universitario de CEMIC, RELACOEM, Bulgarian SmartMS COVID-19 Dataset, ABEM-Brazilian MS Patients Association, University Hospital Rigshospitalet, Universidade Estadual Paulista (UNESP), REDONE.br-Brazilian Registry of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, Irmandade da Santa Casa de Misericórdia de São Paulo, Ramos Mejia Hospital-EMA, Imperial College, Mental Health Area, EMA, Cemcat, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Ospedale San Raffaele
المصدر: Scientia
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Neurology
article-version (Version of Record) 3مصطلحات موضوعية: Male, Dimethyl Fumarate, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Otros calificadores::Otros calificadores::/complicaciones [Otros calificadores], chemistry.chemical_compound, 0302 clinical medicine, Natalizumab, virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], Medicine, 10. No inequality, COVID-19 (Malaltia) - Complicacions, B-Lymphocytes, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis [DISEASES], Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], Middle Aged, 3. Good health, Hospitalization, enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES], Cohort, Female, Rituximab, Life Sciences & Biomedicine, Research Article, medicine.drug, Adult, medicine.medical_specialty, Multiple Sclerosis, Adolescent, Clinical Neurology, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antibodies, Monoclonal, Humanized, Young Adult, 03 medical and health sciences, Internal medicine, Humans, Risk factor, Aged, 030203 arthritis & rheumatology, Science & Technology, Expanded Disability Status Scale, SARS-CoV-2, business.industry, COVID-19, Odds ratio, Respiration, Artificial, Cross-Sectional Studies, Siponimod, chemistry, Ocrelizumab, Neurosciences & Neurology, Neurology (clinical), business, Esclerosi múltiple - Tractament, 030217 neurology & neurosurgery, Other subheadings::Other subheadings::/complications [Other subheadings]
وصف الملف: application/pdf; Print-Electronic
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdbb50404f289c1a781c29206cd86560
https://doi.org/10.1212/wnl.0000000000012753 -
3
المؤلفون: Stephanie Humblet-Baron, Stanislas Goriely, Pieter Pannus, B. Willems, Leo Heyndrickx, Sophie Servais, Kevin K. Ariën, Lorenzo Canti, Grégory Ehx, Adrian Liston, Johan Michiels, Aurélie Henry, Yves Beguin, Maria E Goossens, Arnaud Marchant, Frédéric Baron, Evelyne Willems, Isabelle Desombere, Julika Neumann, Laurence Seidel
المصدر: Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-12 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology, 14 (1مصطلحات موضوعية: Cancer Research, Transplantation Conditioning, medicine.medical_treatment, Hematopoietic stem cell transplantation, T-SNE, IMMUNOGENICITY, COVID-19 VACCINE, Immunologie, Neutralizing antibody, RC254-282, Hematology, BNT162b2 mRNA vaccine, Hematopoietic cell transplantation, biology, Immunogenicity, Hematopoietic Stem Cell Transplantation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, RECOVERY, Vaccination, Titer, Oncology, Plasmacytoid dendritic cells, Rituximab, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, COVID-19 Vaccines, Switched B cells, Transplantation Immunology, Internal medicine, medicine, Humans, Transplantation, Homologous, Diseases of the blood and blood-forming organs, Molecular Biology, BNT162 Vaccine, Allogeneic, Aged, Science & Technology, business.industry, SARS-CoV-2, Research, COVID-19, EFFICACY, Antibodies, Neutralizing, Immunization, Immunology, biology.protein, RC633-647.5, business, Vaccine, Hématologie
وصف الملف: Electronic; 1 full-text file(s): application/pdf
-
4
المؤلفون: Marc De Man, Pascal Pierre, Erik Vanderstraeten, Ghislain Houbiers, Lionel D'Hondt, Jacques Van Der Auwera, Hassan Rezaei Kalantari, Amélie Deleporte, Ahmad Awada, Lieveke Ameye, Alain Hendlisz, Thierry Delaunoit, Stéphanie Laurent, Francesco Sclafani, Bjorn Ghillemijn, Marylene Clausse, Marianne Paesmans, Angelique Covas, Marc Van den Eynde, Frédéric Forget, Philippe Vergauwe, Stéphane Holbrechts
المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (MGD) Service d'oncologie médicale, UCL - (SLuc) Service d'oncologie médicale, UCL - (SLuc) Centre du cancer, Medical Oncology
المصدر: Cancer medicine, Vol. 10, no. 13, p. 4366-4374 (2021)
Cancer Medicine, Vol 10, Iss 13, Pp 4366-4374 (2021)
Cancer Medicineمصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, MONOTHERAPY, MULTICENTER, cisplatin, Gastroesophageal Junction Adenocarcinoma, THERAPY, Gastroenterology, DOUBLE-BLIND, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Clinical endpoint, docetaxel, Medicine, hematological growth factors, Fatigue, RC254-282, Original Research, Aged, 80 and over, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, CANCER, Progression-Free Survival, Anorexia, Oncology, Docetaxel, 030220 oncology & carcinogenesis, Toxicity, fortnightly, Vomiting, Female, Esophagogastric Junction, Fluorouracil, medicine.symptom, Life Sciences & Biomedicine, medicine.drug, Adult, Diarrhea, medicine.medical_specialty, Neutropenia, MODIFIED DOCETAXEL, Adenocarcinoma, Drug Administration Schedule, gastroesophageal cancer, 03 medical and health sciences, Stomach Neoplasms, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, 5-FU, Aged, Febrile Neutropenia, Cisplatin, Science & Technology, business.industry, gastric cancer, NIVOLUMAB, Clinical Cancer Research, weekly, medicine.disease, FLUOROURACIL, 5‐FU, 030104 developmental biology, PLUS CHEMOTHERAPY, business, Febrile neutropenia
وصف الملف: Print-Electronic
-
5
المؤلفون: J. Randolph Hecht, Teresa Macarulla, Joon Oh Park, Richard Greil, Johanna C. Bendell, Sara Lonardi, Sujata Rao, Hong Wang, Andres J. Muñoz Martin, Eric Van Cutsem, Charles D. Lopez, Yong Lin, Ivelina Gueorguieva, Rebecca R. Hozak, Baek Yeol Ryoo, Hao-Wen Sim
المصدر: Journal of Clinical Oncology. 39:1108-1118
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Leucovorin, Kaplan-Meier Estimate, Deoxycytidine, Polyethylene Glycols, 0302 clinical medicine, FOLFOX, Antineoplastic Combined Chemotherapy Protocols, Outcome Assessment, Health Care, Fatigue, Aged, 80 and over, Interleukin, Middle Aged, CHEMOTHERAPY, Interleukin-10, Oxaliplatin, Fluorouracil, 030220 oncology & carcinogenesis, Disease Progression, Female, Life Sciences & Biomedicine, Carcinoma, Pancreatic Ductal, medicine.drug, Adult, medicine.medical_specialty, 03 medical and health sciences, Folinic acid, SERUM INTERLEUKIN-18, Internal medicine, PEG ratio, medicine, Humans, In patient, Aged, Science & Technology, business.industry, ADENOCARCINOMA, Thrombocytopenia, Gemcitabine, digestive system diseases, Pancreatic Neoplasms, 030104 developmental biology, Drug Resistance, Neoplasm, business
وصف الملف: Print-Electronic
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e781bc559bf60b1f653bfb3a754fc9d5
https://doi.org/10.1200/jco.20.02232 -
6
المصدر: European Journal of Hospital Pharmacy. 29:280-283
مصطلحات موضوعية: Male, BIOAVAILABILITY, IMPACT, Levofloxacin, CIPROFLOXACIN, 030226 pharmacology & pharmacy, Enteral administration, PHARMACY SERVICE, 0302 clinical medicine, Anti-Infective Agents, Acute care, ABSORPTION, Antimicrobial stewardship, Pharmacology & Pharmacy, 030212 general & internal medicine, General Pharmacology, Toxicology and Pharmaceutics, Child, Aged, 80 and over, Drug Administration Routes, Middle Aged, Antimicrobial, Ciprofloxacin, DRUG INCOMPATIBILITY, Child, Preschool, Doxycycline, Female, FERROUS SULFATE, 1115 Pharmacology and Pharmaceutical Sciences, Life Sciences & Biomedicine, INTERVENTIONS, medicine.drug, Adult, MICROBIOLOGY, medicine.medical_specialty, Adolescent, Iron, CALCIUM, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, Dosing, Aged, Retrospective Studies, Science & Technology, business.industry, Infant, PHARMACY ADMINISTRATION, Concomitant, business, HOSPITAL
-
7
المؤلفون: Huamao M. Lin, Myung-Ju Ahn, Pingkuan Zhang, Angelo Delmonte, Marcello Tiseo, D. Ross Camidge, Frank Griesinger, Scott N. Gettinger, Dong Wan Kim, Maria Rosario Garcia Campelo, Maximilian Hochmair, Enriqueta Felip, Ki Hyeong Lee, Alexander I. Spira, Q. Ni, Neeraj Gupta, Michael J. Hanley, James Chih-Hsin Yang, Hye Ryun Kim, Sanjay Popat, Ji Youn Han, Raffaele Califano
المساهمون: Institut Català de la Salut, [Camidge DR] University of Colorado Cancer Center, Aurora, CO. [Kim HR] Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. [Ahn MJ] Samsung Medical Center, Seoul, South Korea. [Yang JCH] National Taiwan University Hospital, Taipei, Taiwan. [Han JY] National Cancer Center, Goyang, South Korea. [Hochmair MJ] Department of Respiratory and Critical Care Medicine, Krankenhaus Nord–Klinik Floridsdorf, Vienna, Austria. [Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
Journal of Clinical Oncologyمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Other subheadings::Other subheadings::/drug therapy [Other subheadings], ALECTINIB, 0302 clinical medicine, QUALITY-OF-LIFE, Carcinoma, Non-Small-Cell Lung, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, OUTCOMES, QLQ-C30, ORIGINAL REPORTS, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], CHEMOTHERAPY, Middle Aged, Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Progression-Free Survival, Survival Rate, SAFETY, 030220 oncology & carcinogenesis, Female, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Brigatinib, diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], medicine.drug_class, EGFR, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antineoplastic Agents, Young Adult, 03 medical and health sciences, Organophosphorus Compounds, Crizotinib, Internal medicine, medicine, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Progression-free survival, Thoracic Oncology, Lung cancer, Survival rate, Aged, Medicaments antineoplàstics - Ús terapèutic - Eficàcia, Science & Technology, business.industry, Receptor Protein-Tyrosine Kinases, 1103 Clinical Sciences, KINASE INHIBITOR, neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], EFFICACY, medicine.disease, Interim analysis, ALK inhibitor, EML4-ALK FUSION GENE, Pyrimidines, 030104 developmental biology, Quality of Life, business, Pulmons - Càncer - Tractament
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc7081ad44ad8535823a537fe2ae82e
https://doi.org/10.1200/jco.20.00505 -
8
المؤلفون: Johan Maertens, Annoek E.C. Broers, Yvette van Norden, Mojca Jongen-Lavrencic, Gert J. Ossenkoppele, Michel van Gelder, Jan J. Cornelissen, Wendelien Zeijlemaker, Burak Kalin, Ellen Meijer, Dimitri Breems, Eric Braakman, Tim Grob
المساهمون: Hematology, Hematology laboratory, CCA - Cancer Treatment and quality of life, Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: BLOOD ADVANCES, 4(18), 4430-4437. American Society of Hematology
Blood advances, 4(18), 4430-4437. American Society of Hematology
Kalin, B, van Norden, Y, van Gelder, M, Breems, D, Maertens, J, Jongen-Lavrencic, M, Broers, A E C, Braakman, E, Grob, T, Zeijlemaker, W, Ossenkoppele, G J, Meijer, E & Cornelissen, J J 2020, ' Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation ', BLOOD ADVANCES, vol. 4, no. 18, pp. 4430-4437 . https://doi.org/10.1182/BLOODADVANCES.2020002074
Blood Adv
Blood advances, 4(18), 4430-4437. The American Society of Hematologyمصطلحات موضوعية: Adult, Oncology, MAINTENANCE THERAPY, medicine.medical_specialty, Adolescent, medicine.medical_treatment, Decitabine, ACUTE MYELOID-LEUKEMIA, Hematopoietic stem cell transplantation, SINGLE-AGENT, HEMATOLOGIC MALIGNANCIES, PROPHYLAXIS, Donor lymphocyte infusion, Young Adult, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, AML, Maintenance therapy, Internal medicine, Panobinostat, medicine, POSTTRANSPLANTATION CYCLOPHOSPHAMIDE, Humans, Transplantation, Homologous, Lymphocytes, RESIDUAL DISEASE DETECTION, Aged, Transplantation, Cytopenia, Science & Technology, ACUTE MYELOGENOUS LEUKEMIA, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, medicine.disease, BONE-MARROW-TRANSPLANTATION, chemistry, International Prognostic Scoring System, 030220 oncology & carcinogenesis, business, Life Sciences & Biomedicine, 030215 immunology, medicine.drug
وصف الملف: application/pdf; Print
-
9
المؤلفون: Ellen Copson, Hiltrud Brauch, Robin Michelet, Matthias Schwab, Wilhelm Huisinga, Lena Klopp-Schulze, Patrick Neven, Diana Eccles, Nathalie K. Zgheib, Thomas E. Mürdter, Sylvia Chen, Ron H.J. Mathijssen, Werner Schroth, Arafat Tfayli, Markus Joerger, Balram Chowbay, Anna Mueller-Schoell, Charlotte Kloft, Stijn L.W. Koolen
المساهمون: Medical Oncology
المصدر: Clinical Pharmacology & Therapeutics, 108(3), 661-670. Wiley-Blackwell
مصطلحات موضوعية: Oncology, obesity, Pharmacogenomic Variants, CYP2D6 GENOTYPE, Overweight, 030226 pharmacology & pharmacy, 0302 clinical medicine, endoxifen plasma, Pharmacology (medical), Pharmacology & Pharmacy, skin and connective tissue diseases, Aged, 80 and over, Endoxifen, Age Factors, WOMEN, PREMENOPAUSAL PATIENTS, Middle Aged, Cytochrome P-450 CYP2D6, 030220 oncology & carcinogenesis, Female, medicine.symptom, Life Sciences & Biomedicine, METABOLITE CONCENTRATIONS, medicine.drug, Adult, medicine.medical_specialty, CYP2D6, Antineoplastic Agents, Hormonal, ADJUVANT TAMOXIFEN, Breast Neoplasms, Young Adult, 03 medical and health sciences, Breast cancer, breast cancer, Pharmacokinetics, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, DOSE-ESCALATION, Computer Simulation, Dosing, EXPOSURE, METAANALYSIS, Aged, Pharmacology, Science & Technology, PHARMACOGENETICS, business.industry, Body Weight, Models, Theoretical, medicine.disease, Obesity, SERUM CONCENTRATIONS, Tamoxifen, 500 Naturwissenschaften und Mathematik::570 Biowissenschaften, Biologie::572 Biochemie, business
وصف الملف: Print-Electronic; text; application/pdf
-
10
المؤلفون: Seock-Ah Im, Patrick Neven, John Crown, Rosa-Maria Espadero, Noelia Martínez, Yen-Shen Lu, Jonas Bergh, Thomas Bogenrieder, J. Alejandro Pérez-Fidalgo, Peter Schmid, Guy Jerusalem, Laura Schlieker, Serafin Morales, Dennis Chin-Lun Huang, Douglas Adamson, Javier Cortes, Anthony Gonçalves, Keun Seok Lee, Marie-Paule Sablin, Aleix Prat
المساهمون: Queen Mary University of London (QMUL), Institut Curie [Paris], Karolinska University Hospital [Stockholm], Seoul National University Hospital, National Taiwan University Hospital [Taipei], Ramon & Cajal University Hospital, UZ Leuven - campus Gasthuisberg, Hospital of National Cancer Center [Goyang], Hospital Universitario Arnau de Vilanova de Lleida, Biomedical Research Institute [Valencia, Spain] (INCLIVA ), Ninewells Hospital and Medical School [Dundee], Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Centre Hospitalier Universitaire de Liège (CHU-Liège), Boehringer Ingelheim Pharma GmbH & Co. KG, St Vincent's University Hospital, Vall d'Hebron Institute of Oncology [Barcelone] (VHIO), Vall d'Hebron University Hospital [Barcelona], Institute of Oncology Prof. Dr. Alexandru Trestioreanu (IOB), Institut Català de la Salut, [Schmid P] Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK. [Sablin MP] Department of Drug Development and Innovation, Institut Curie, Paris, France. [Bergh J] Department of Oncology-Pathology, Karolinska Institutet and Breast Cancer Centre, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden. [Im SA] Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. [Lu YS] Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. [Martínez N] Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. [Cortés J] Breast Cancer Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Oncology, IOB Institute of Oncology, Quironsalud Group, Madrid and Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Breast Cancer Research
Breast Cancer Research, 2021, 23 (1), pp.8. ⟨10.1186/s13058-020-01382-8⟩
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Scientiaمصطلحات موضوعية: Oncology, Receptor, ErbB-2, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Exemestane, Antineoplastic Combined Chemotherapy Protocols, terapéutica::farmacoterapia::farmacoterapia combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Clinical endpoint, Insulin-like growth factor, Neoplasm Metastasis, Aged, 80 and over, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], 0303 health sciences, education.field_of_study, Hazard ratio, Therapeutics::Drug Therapy::Drug Therapy, Combination [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Disease Management, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Metastatic breast cancer, Treatment Outcome, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, Receptors, Progesterone, Life Sciences & Biomedicine, Research Article, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Population, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Hormone receptor-positive, Humans, Xentuzumab, Everolimus, education, Adverse effect, Aged, Neoplasm Staging, 030304 developmental biology, Science & Technology, business.industry, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Androstadienes, chemistry, Mama - Càncer - Tractament, Medicaments - Eficàcia, business, HER2-negative
وصف الملف: application/pdf; Electronic
إعادة تعيين المنقحات
عرض المنقحات (%%عد%%)
Full Text via ClinicalKey